e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Novel approaches to human studies in allergy and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2014 abstract - Influence of a Th2 immune response on airway remodeling in asthma
K. Dietz, M. Ulrich, H. Baarsma, K. Suttner, M. Königshoff, C. Schmidt-Weber, U. Zissler (München, Germany)
Source:
International Congress 2014 – Novel approaches to human studies in allergy and asthma
Session:
Novel approaches to human studies in allergy and asthma
Session type:
Oral Presentation
Number:
4834
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Dietz, M. Ulrich, H. Baarsma, K. Suttner, M. Königshoff, C. Schmidt-Weber, U. Zissler (München, Germany). LSC 2014 abstract - Influence of a Th2 immune response on airway remodeling in asthma. Eur Respir J 2014; 44: Suppl. 58, 4834
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
D-tryptophan influences allergic airway inflammation and Th2 immune responses
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
HMGB1 expression and function in the allergic airway immune response
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Immune modulation of the T-cell response in asthma through Wnt10b
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Discrimination of bronchial inflammatory phenotype of asthmatic patients by using the electronic nose
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Peripheral blood Th17 / Treg ratio increases in late asthmatic response
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
LSC 2014 abstract - A20 levels in dendritic cells control eosinophilic versus neutrophilic lung inflammation in asthma
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Altered airway microbiome in stable asthma
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma.
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
LSC 2014 abstract - Targeting of microRNAs can restore innate anti-viral response in asthma
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Association between airway inflammation, airway remodelling and physiological changes in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Th2 subsetting of U-BIOPRED asthma subjects based on airway transciptomic profiles
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept